<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1029</article-id>
      <article-id pub-id-type="doi">10.51847/QdA0hbAnDG</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of Ayush Alternative Medicine Interventions in the COVID-19 Pandemic</article-title>
      </title-group>
                  <pub-date pub-type="epub">
        <day>11</day>
        <month>04</month>
        <year>2023</year>
      </pub-date>
      <volume>14</volume>
      <issue>2</issue>
      <fpage>37</fpage>
      <lpage>43</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>The five Indian systems of alternative and complementary medicine (Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy) are frequently used to treat &quot;COVID-19&quot; throughout the country (referred to simply as &quot;AYUSH&quot;). At the outset of the pandemic, &quot;The Ministry of AYUSH&quot; (the governing authority of the Indian system of medicine) issued recommendations for the use of particular herbs and acts to improve immunity, based on the advice of an advisory council of &quot;AYUSH&quot; doctors and scant evidence. Some of these suggestions involved using traditional herbs and practices, which have been used for centuries and are effective in treating a wide range of conditions, including fever, sore throat, and breathing difficulties, as well as acting as a non-specific leniency enhancer thanks to their anti-viral, anti-bacterial, and anti-microbial properties. A number of the formulations recommended here—including AYUSH 64, Chyawanprash, Guduchi Ghanavati, Arsenic Album, Kabasur Kudineer, and Nilavembu Kudineer—have been the subject of scientific research into their putative prophylactic or therapeutic benefits. </p>
      </abstract>
      <kwd-group>
              </kwd-group>
    </article-meta>
  </front>
</article>